MST1R and urinary bladder carcinoma: To investigate this hypothesis, we initially assessed the HIF-2α mRNA levels in bladder cancer cells and observed minimal fluctuations in HIF-2α levels irrespective of the RON expression levels in cancer cells (Fig. 4B).